Cara Therapeutics Inc. (TVRD)
NASDAQ · Healthcare
Cara Therapeutics Inc. Shareholder Equity 2012–2024
Cara Therapeutics Inc. annual/quarterly shareholder equity history from 2013 to 2024. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Cara Therapeutics Inc. shareholder equity for the quarter ending December 31, 2024 were -91.1M, a 46.85% increase year-over-year.
- Cara Therapeutics Inc. shareholder equity for 2024 were -91.1M, a 46.85% increase from 2023.
- Cara Therapeutics Inc. shareholder equity for 2023 were -62.1M, a 139.08% decrease from 2022.
- Cara Therapeutics Inc. shareholder equity for 2022 were 158.8M, a 30.21% decrease from 2021.
- Cara Therapeutics Inc. shareholder equity for 2021 were 227.5M.
Shareholder Equity
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Cara Therapeutics Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2024 | $-91 |
| 2023 | $-62 |
| 2022 | $159 |
| 2021 | $228 |
| 2020 | $249 |
| 2019 | $187 |
| 2018 | $134 |
| 2017 | $87 |
| 2016 | $51 |
| 2015 | $105 |
| 2014 | $52 |
| 2013 | $-54 |
| Cara Therapeutics Inc. Quarterly Shareholder Equity (Millions of US $) | |
|---|---|
| 2024-12-31 | $-91 |
| 2023-12-31 | $-62 |
| 2022-12-31 | $159 |
| 2021-12-31 | $228 |
| 2020-12-31 | $249 |
| 2019-12-31 | $187 |
| 2018-12-31 | $134 |
| 2017-12-31 | $87 |
| 2016-12-31 | $51 |
| 2015-12-31 | $105 |
| 2014-12-31 | $52 |
| 2013-12-31 | $-54 |
Cara Therapeutics Inc. Shareholder Equity — FAQ
Cara Therapeutics Inc. (TVRD) shareholder equity over the last 13 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see TVRD's shareholder equity history?
The chart and table above show Cara Therapeutics Inc.'s shareholder equity by year and by quarter, including the growth rate.